Tengonermin (ARENEGYR) is a vascular-targeting agent consisting of the humanTumour Necrosis Factor-α (TNF-α)conjugated with theCNGRCG peptide. Tengonermin increases penetration of intratumoral chemotherapy and T-cell infiltration by modifying the tumour microenvironment^[1][2].

NGR-hTNF 是一种实体瘤治疗剂，通过 NGR 基序特异性靶向血管生成肿瘤血管^[1]。

1960461-99-7

Please store the product under the recommended conditions in the Certificate of Analysis.